Related Experiment Videos
Platelet serotonin pathway in menstrual migraine
L Fioroni1, G D Andrea, M Alecci
1Department of Obstetrics and Gynaecology, University of Modena, Italy.
Cephalalgia : an International Journal of Headache
|October 1, 1996
Summary
Women with menstrual migraine show reduced serotonin (5-hydroxytryptamine or 5HT) availability before attacks. This may be due to increased breakdown or reduced production of 5HT, potentially triggering migraines.
Area of Science:
- Neuroscience
- Biochemistry
- Gynecology
Background:
- Migraine is a complex neurological disorder.
- Menstrual migraine is a subtype often linked to hormonal fluctuations.
- Serotonin (5-hydroxytryptamine or 5HT) plays a role in migraine pathophysiology.
Purpose of the Study:
- To investigate 5-hydroxytryptamine (5HT) anomalies in menstrual migraine patients.
- To compare 5HT, 5-hydroxyindoleacetic acid (5HIAA), and monoaminoxidase (MAO) activity between patients and controls.
- To examine these factors during different menstrual cycle phases.
Main Methods:
- Blood samples were collected from menstrual migraine patients and healthy controls.
- Samples were analyzed during the follicular and luteal phases of the menstrual cycle.
- Levels of 5HT, 5HIAA, and platelet MAO activity were measured.
Main Results:
- In controls, 5HT levels were stable, while 5HIAA and MAO activity increased in the luteal phase.
- Menstrual migraine patients showed increased 5HIAA and MAO activity in the luteal phase compared to controls.
- Unlike controls, 5HT levels decreased in the luteal phase for migraine patients.
Conclusions:
- Reduced 5HT availability is suggested in menstrual migraine.
- Increased 5HT catabolism and/or reduced synthesis may contribute to migraine predisposition.
- These 5HT changes during the luteal phase could be a trigger for menstrual migraine attacks.